- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 343
Polystream pulls in $12m from series A
The 3D game streaming platform has collected $12m in an Intel Capital-led round that also featured Wargaming Group, with the funds to go to hiring.
Apr 4, 2019Oxford Nanopore sets sights on IPO
The Oxford University genetic sequencing spinout is reportedly mulling an IPO that would provide exits to investors including commercialisation firm IP Group.
Apr 4, 2019Intel spreads $117m across 14 companies
Intel's corporate venturing vehicle has announced participation in 14 funding deals and backed non-profit organisation HBCU.vc.
Apr 2, 2019CIC collates $196m in new capital
The fresh capital, anchored by University of Cambridge and its Endowment Fund, will enable patient capital-orientated vehicle Cambridge Innovation Capital to make new bets and sustain investments in its existing portfolio.
Apr 1, 2019Oxford Genetics locks in $8.5m
Founding investor Mercia Technologies joined fund manager Invesco for the synthetic biology contractor’s latest round, taking its total funding past the $25m mark.
Apr 1, 2019Corporate venturing deal net: 25-29 March 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 29, 2019Moullet made CTO at CNRS
Jean-Luc Moullet has joined the French National Center for Scientific Research, also known as CNRS, as its chief technology officer.
Mar 28, 2019Cambridge Enterprise refreshes board
The office has appointed three directors and two advisers including Russell Cowburn, professor of experimental physics, and Cancer Research UK's Tony Hickson.
Mar 28, 2019GeoSpock locates additional capital
Parkwalk Advisors has injected an additional $2.6m into GeoSpock, two months after the Cambridge spinout secured $12.8m in a round co-led by the fund manager.
Mar 28, 2019Cytena cites $3.4m
HTGF has returned to back Freiburg's single cell-dispensing spinout Cytena after previously featuring in the company’s $1.3m round in 2015.
Mar 28, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


